Broadly speaking the United Kingdom appears to have embraced this pathway more than most other

countries but even there, there are divergent Selleck Buparlisib views on what models of care should be implemented. One model, developed at St. George hospital in Sydney, is as follows: The RSC team oversees a program deliberately titled ‘HOPE: Helping Older Patients with End-stage kidney disease’. The multidisciplinary team (MDT) is essentially an integration of Renal and Palliative Medicine, utilising the skills of both disciplines to ensure optimum nephrology care whilst adding a focus on symptom control, holistic physical and spiritual care and, when appropriate, the facilitation of a ‘good death’. “
“SUNDAY 8 SEPTEMBER 2013 Plaza P9 1330 Welcome 1340–1410 Analysis of Tissue Injury and Metabolism by Multiphoton Microscopy – Washington Sanchez 1410–1440 Animal Models of Cardio-Renal Injury – Michael Zhang 1440–1510 Role of Uraemic PF-01367338 concentration Toxins in Cardiac and Renal Disease: Implications for Cardio-Renal Syndrome – Andrew Kompa 1510–1530 Afternoon Tea 1530–1600 Role of miRNAs in Kidney Disease – Phillip Kantharidis 1600–1630 Role

of Regulatory T cells in Kidney Disease – Stephen Alexander 1630 Close “
“This supplement is the seventh publication of CARI guidelines in Nephrology and the contents cover the three broad kidney disease areas – chronic kidney disease, dialysis and transplantation. All subtopics have been subject to the CARI rigour with respect to locating the evidence, critically appraising the evidence and drafting the Guideline Recommendations. When possible, appropriate Suggestions for Clinical Care have been provided. The evidence grading system used to categorize the evidence is still the modified NHMRC system previously used. However, we plan to use the GRADE evidence rating system for future publications because it offers a more sophisticated and comprehensive means of appraising the evidence. The GRADE system also

takes into account the fact that for example, a randomized controlled Diflunisal trial (RCT) may not be practical or ethical to undertake and for many questions, other types of study design will provide the best evidence. It also helps to take account of the methodological quality of individual studies and the overall body of evidence rather than such a focus on individual studies. It is particularly noteworthy, that two of the guidelines in this supplement were developed as a joint endeavour between CARI and another organization or group – the ‘Transplantation Nutrition’ and the ‘Type 2 Diabetes: Kidney Disease’ guidelines. The Transplant Nutrition guideline was developed by a team of renal dietitians and transplant physicians working in NSW and then subjected to the usual CARI peer review and public/consumer review process.